978 related articles for article (PubMed ID: 16429394)
121. Tie-1 tyrosine kinase is an independent prognostic indicator for invasive breast cancer.
Tseng LM; Hsu CY; Wang HC; Liu JM; Chang HM; Lo SS; Wu CW; Lui WY; Chi CW
Anticancer Res; 2001; 21(3C):2163-70. PubMed ID: 11501841
[TBL] [Abstract][Full Text] [Related]
122. Hybrid carcinomas of the salivary glands: report of nine cases with a clinicopathologic, immunohistochemical, and p53 gene alteration analysis.
Nagao T; Sugano I; Ishida Y; Asoh A; Munakata S; Yamazaki K; Konno A; Iwaya K; Shimizu T; Serizawa H; Ebihara Y
Mod Pathol; 2002 Jul; 15(7):724-33. PubMed ID: 12118110
[TBL] [Abstract][Full Text] [Related]
123. E-cadherin as a prognostic indicator in primary breast cancer.
Parker C; Rampaul RS; Pinder SE; Bell JA; Wencyk PM; Blamey RW; Nicholson RI; Robertson JF
Br J Cancer; 2001 Dec; 85(12):1958-63. PubMed ID: 11747340
[TBL] [Abstract][Full Text] [Related]
124. [Diagnostic and prognostic significance of FOXA1 expression in molecular subtypes of breast invasive ductal carcinomas].
Liu N; Niu Y; Wang SL; Yu Q; Zhang RJ; Liu TJ
Zhonghua Yi Xue Za Zhi; 2010 May; 90(20):1403-7. PubMed ID: 20646630
[TBL] [Abstract][Full Text] [Related]
125. Angiogenesis and some prognostic parameters of invasive ductal breast carcinoma in women.
Olewniczak S; Chosia M; Kwas A; Kram A; Domagała W
Pol J Pathol; 2002; 53(4):183-8. PubMed ID: 12597334
[TBL] [Abstract][Full Text] [Related]
126. Elevated expression of phosphorylated c-Jun NH2-terminal kinase in basal-like and "triple-negative" breast cancers.
Wang X; Chao L; Li X; Ma G; Chen L; Zang Y; Zhou G
Hum Pathol; 2010 Mar; 41(3):401-6. PubMed ID: 19913278
[TBL] [Abstract][Full Text] [Related]
127. Prognostic markers in triple-negative breast cancer.
Rakha EA; El-Sayed ME; Green AR; Lee AH; Robertson JF; Ellis IO
Cancer; 2007 Jan; 109(1):25-32. PubMed ID: 17146782
[TBL] [Abstract][Full Text] [Related]
128. Dedifferentiated adenoid cystic carcinoma: a clinicopathologic study of 6 cases.
Nagao T; Gaffey TA; Serizawa H; Sugano I; Ishida Y; Yamazaki K; Tokashiki R; Yoshida T; Minato H; Kay PA; Lewis JE
Mod Pathol; 2003 Dec; 16(12):1265-72. PubMed ID: 14681328
[TBL] [Abstract][Full Text] [Related]
129. Expression and prognostic significance of CK19 in canine malignant mammary tumours.
Gama A; Alves A; Schmitt F
Vet J; 2010 Apr; 184(1):45-51. PubMed ID: 19264518
[TBL] [Abstract][Full Text] [Related]
130. Node-related factors and survival in node-positive breast carcinomas.
Sivridis E; Giatromanolaki A; Galazios G; Koukourakis MI
Breast; 2006 Jun; 15(3):382-9. PubMed ID: 16135406
[TBL] [Abstract][Full Text] [Related]
131. Coexpression of beta1,6-N-acetylglucosaminyltransferase V glycoprotein substrates defines aggressive breast cancers with poor outcome.
Siddiqui SF; Pawelek J; Handerson T; Lin CY; Dickson RB; Rimm DL; Camp RL
Cancer Epidemiol Biomarkers Prev; 2005 Nov; 14(11 Pt 1):2517-23. PubMed ID: 16284372
[TBL] [Abstract][Full Text] [Related]
132. Identification of different subtypes of breast cancer using tissue microarray.
Munirah MA; Siti-Aishah MA; Reena MZ; Sharifah NA; Rohaizak M; Norlia A; Rafie MK; Asmiati A; Hisham A; Fuad I; Shahrun NS; Das S
Rom J Morphol Embryol; 2011; 52(2):669-77. PubMed ID: 21655659
[TBL] [Abstract][Full Text] [Related]
133. [Immunohistochemical study of P-cadherin in breast cancer].
Kovács A; Walker RA; Nagy A; Gomba S; Jones L; Dearing S
Orv Hetil; 2002 Feb; 143(8):405-9. PubMed ID: 11921707
[TBL] [Abstract][Full Text] [Related]
134. [The value of searching for additional prognostic factors in combination with Nottingham Prognostic Index in breast carcinoma patients].
Jakić-Razumović J; Corić M; Vrbanec D; Babić D; Hlupić L; Belev B
Lijec Vjesn; 2005; 127(1-2):3-7. PubMed ID: 16145866
[TBL] [Abstract][Full Text] [Related]
135. Mesothelial markers in high-grade breast carcinoma.
Duhig EE; Kalpakos L; Yang IA; Clarke BE
Histopathology; 2011 Nov; 59(5):957-64. PubMed ID: 22092407
[TBL] [Abstract][Full Text] [Related]
136. Histone deacetylase-1 and -3 protein expression in human breast cancer: a tissue microarray analysis.
Krusche CA; Wülfing P; Kersting C; Vloet A; Böcker W; Kiesel L; Beier HM; Alfer J
Breast Cancer Res Treat; 2005 Mar; 90(1):15-23. PubMed ID: 15770522
[TBL] [Abstract][Full Text] [Related]
137. Correlation between histological grade and c-erbB2 oncoprotein overexpression in infiltrating ductal carcinoma of breast.
Looi LM; Cheah PL; Yap SF
Malays J Pathol; 1997 Jun; 19(1):35-9. PubMed ID: 10879240
[TBL] [Abstract][Full Text] [Related]
138. Mitotic counts provide additional prognostic information in grade II mammary carcinoma.
Lynch J; Pattekar R; Barnes DM; Hanby AM; Camplejohn RS; Ryder K; Gillett CE
J Pathol; 2002 Mar; 196(3):275-9. PubMed ID: 11857489
[TBL] [Abstract][Full Text] [Related]
139. Basal-like subtype breast cancers in women older than 40 years of age.
Erşahin C; Chivukula M; Bhargava R; Dabbs DJ
Int J Surg Pathol; 2010 Feb; 18(1):42-7. PubMed ID: 19372082
[TBL] [Abstract][Full Text] [Related]
140. Vimentin and laminin expression is associated with basal-like phenotype in both sporadic and BRCA1-associated breast carcinomas.
Rodríguez-Pinilla SM; Sarrió D; Honrado E; Moreno-Bueno G; Hardisson D; Calero F; Benítez J; Palacios J
J Clin Pathol; 2007 Sep; 60(9):1006-12. PubMed ID: 17105822
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]